These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 31852271)

  • 1. Ovarian reserve markers in women using various hormonal contraceptives.
    Landersoe SK; Forman JL; Birch Petersen K; Larsen EC; Nøhr B; Hvidman HW; Nielsen HS; Nyboe Andersen A
    Eur J Contracept Reprod Health Care; 2020 Feb; 25(1):65-71. PubMed ID: 31852271
    [No Abstract]   [Full Text] [Related]  

  • 2. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception.
    Bentzen JG; Forman JL; Pinborg A; Lidegaard Ø; Larsen EC; Friis-Hansen L; Johannsen TH; Nyboe Andersen A
    Reprod Biomed Online; 2012 Dec; 25(6):612-9. PubMed ID: 23069740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
    Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
    Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Müllerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals.
    Hariton E; Shirazi TN; Douglas NC; Hershlag A; Briggs SF
    Am J Obstet Gynecol; 2021 Nov; 225(5):515.e1-515.e10. PubMed ID: 34126087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian reserve markers and endocrine profile during oral contraception: Is there a link between the degree of ovarian suppression and AMH?
    Landersoe SK; Larsen EC; Forman JL; Birch Petersen K; Kroman MS; Frederiksen H; Juul A; Nøhr B; Løssl K; Nielsen HS; Nyboe Andersen A
    Gynecol Endocrinol; 2020 Dec; 36(12):1090-1095. PubMed ID: 32362164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal and intrauterine methods for contraception for women aged 25 years and younger.
    Krashin J; Tang JH; Mody S; Lopez LM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD009805. PubMed ID: 26280888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.
    Lopez LM; Grey TW; Stuebe AM; Chen M; Truitt ST; Gallo MF
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD003988. PubMed ID: 25793657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetic analysis of levonorgestrel-releasing intrauterine systems and levonorgestrel-containing contraceptives with oral or subdermal administration route.
    Hofmann BM; Apter D; Bitzer J; Reinecke I; Serrani M; Höchel J; Merz M
    Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):417-426. PubMed ID: 33006493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction value of anti-Mullerian hormone (AMH) serum levels and antral follicle count (AFC) in hormonal contraceptive (HC) users and non-HC users undergoing IVF-PGD treatment.
    Bas-Lando M; Rabinowitz R; Farkash R; Algur N; Rubinstein E; Schonberger O; Eldar-Geva T
    Gynecol Endocrinol; 2017 Oct; 33(10):797-800. PubMed ID: 28454495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age.
    Borgatta L; Buhling KJ; Rybowski S; Roth K; Rosen K
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):372-9. PubMed ID: 27494570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contraceptive-specific antimüllerian hormone values in reproductive-age women: a population study of 42,684 women.
    Nelson SM; Ewing BJ; Gromski PS; Briggs SF
    Fertil Steril; 2023 Jun; 119(6):1069-1077. PubMed ID: 36801456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian reserve markers after discontinuing long-term use of combined oral contraceptives.
    Landersoe SK; Birch Petersen K; Sørensen AL; Larsen EC; Martinussen T; Lunding SA; Kroman MS; Nielsen HS; Nyboe Andersen A
    Reprod Biomed Online; 2020 Jan; 40(1):176-186. PubMed ID: 31831368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Circulating Anti-Müllerian Hormone in Women Using Hormonal Contraception: A Systematic Review.
    Amer SAKS; James C; Al-Hussaini TK; Mohamed AA
    J Womens Health (Larchmt); 2020 Jan; 29(1):100-110. PubMed ID: 31314652
    [No Abstract]   [Full Text] [Related]  

  • 16. Ovarian function during hormonal contraception assessed by endocrine and sonographic markers: a systematic review.
    D'Arpe S; Di Feliciantonio M; Candelieri M; Franceschetti S; Piccioni MG; Bastianelli C
    Reprod Biomed Online; 2016 Oct; 33(4):436-448. PubMed ID: 27527655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of bacterial vaginosis, Trichomonas vaginalis and Candida albicans infection among new users of combined hormonal contraception vs LNG-IUS.
    Rezk M; Sayyed T; Masood A; Dawood R
    Eur J Contracept Reprod Health Care; 2017 Oct; 22(5):344-348. PubMed ID: 28849960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration, recency, and type of hormonal contraceptive use and antimüllerian hormone levels.
    Bernardi LA; Weiss MS; Waldo A; Harmon Q; Carnethon MR; Baird DD; Wise LA; Marsh EE
    Fertil Steril; 2021 Jul; 116(1):208-217. PubMed ID: 33752880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception.
    Johnson LN; Sammel MD; Dillon KE; Lechtenberg L; Schanne A; Gracia CR
    Fertil Steril; 2014 Sep; 102(3):774-781.e3. PubMed ID: 24934488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New knowledge in the physiology of hormonal contraceptives.
    Lobo RA; Stanczyk FZ
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1499-507. PubMed ID: 8178898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.